The Global Drug Facility: a unique, holistic and pioneering approach to drug procurement and management
Robert Matiru, Timothy Ryan
Volume 85, Number 5, May 2007, 348-353
Table 5. Areas of collaboration between the Global Drug Facility and the Global Fund to Fight AIDS, Tuberculosis and Malaria, 2004–2006
| Year | Area of collaboration |
|---|---|
| 2004–2006 | 17 principal recipients of funding from Global Fund used the GDF’s Direct Procurement Service to obtain high-quality, affordable anti-TB drugs |
| 2006 | Technical support was provided by GDF to the Global Fund Secretariat during the competitive selection process for independent third parties conducting sampling and/or testing of pharmaceutical products procured according to the Global Fund’s quality assurance policies |
| 2006 | Following convergence with the Green Light Committee (part of the Stop TB Partnership), the GDF became the mandated procurement mechanism for use in procuring second-line anti-TB drugs to treat multidrug-resistant TB for all supplies funded by the Global Fund |
| 2005 | Conclusion of memorandum of understanding regarding cooperation between the Global Partnership to Stop TB and the Global Fund (19 May 2005) |
| 2005–2006 | Technical support was provided for development of new Global Fund quality assurance policy for procurement of single-source and limited-source anti-TB drugs |